Article
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Dec 2024
Hodan Rachel, Gupta Samir, Weiss Jennifer M, Axell Lisen, Burke Carol A, Chen Lee-May, Chung Daniel C, Clayback Katherine M, Felder Seth, Foda Zachariah, Giardiello Francis M, Grady William, Gustafson Susan, Hagemann Andrea, Hall Michael J, Hampel Heather, Idos Gregory, Joseph Nora, Kassem Nawal, Katona Bryson, Kelly Kaitlyn, Kieber-Emmons AnnMarie, Kupfer Sonia, Lang Katie, Llor Xavier, Markowitz Arnold J, Prats Mariana Moreno, Niell-Swiller Mariana, Outlaw Darryl, Pirzadeh-Miller Sara, Samadder Niloy Jewel, Shibata David, Stanich Peter P, Swanson Benjamin J, Szymaniak Brittany M, Welborn Jeanna, Wiesner Georgia L, Yurgelun Matthew B, Dwyer Mary, Darlow Susan, Diwan Zeenat
Abstract excerpt
Multigene panel testing has allowed for the detection of a growing number of inherited pathogenic/likely pathogenic variants in people at high risk of cancer, including endometrial cancer (EC). Hereditary syndromes associated with EC include Lynch syndrome, PTEN hamartoma tumor syndrome, and Peutz-Jeghers syndrome. This manuscript provides the latest recommendations from the NCCN Guidelines for Genetic/Familial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.